Macalma, Gainab P.

HRN: 19-06-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/01/2023
CEFTRIAXONE 1G (VIAL)
04/01/2023
04/07/2023
IV
2gm
Q24
T/C Sigmoid Volvulus
Waiting Final Action 
04/01/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/01/2023
04/08/2023
IV
500mg
Q8
T/C Sigmoid Volvulus
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: